01:30 PM EDT, 05/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

EMR results now reflect the completed buyout of AspenTech, which performed better than anticipated and contributed to an 11% increase in underlying sales for Control Systems & Software. EMR printed FY Q2 EPS of $1.48 (up 9% Y/Y), $0.07 above the consensus view. We view margin performance during the quarter as particularly encouraging, with adjusted segment EBITA margin expanding 200 bps to 28.0% (a record for the firm). This improvement reflects the company's ongoing efforts to enhance operational efficiency and realize synergies across its recent string of acquisitions. Order activity was also a strength during the quarter, with Discrete bookings notably returning to growth following two years of consistent Y/Y declines, supported by strength in the aerospace & defense markets.